- From the makers of BOTOX® Cosmetic, two
new SkinMedica® acne products help address
skin blemishes and can be combined with in-office
DiamondGlow®
IRVINE,
Calif., April 9, 2024 /PRNewswire/ -- Allergan
Aesthetics, an AbbVie company (NYSE: ABBV), today announced the
launch of two new products from SkinMedica® by the
makers of BOTOX® Cosmetic. The SkinMedica®
Acne Clarifying Treatment and SkinMedica® Pore Purifying
Gel Cleanser are breakthroughs in skincare, providing effective and
balanced care for people with acne-prone skin. The two products,
along with the SkinMedica® Pore Purifying Pro-Infusion
Serum, used in-office with DiamondGlow®, complete the
protocol, providing acne sufferers a continuum of products to help
address their skin concerns.
"Acne is the most common skin concern in the US.1 It
is also the primary reason patients schedule an office visit with
their provider.2 For 25 years,
SkinMedica® has been dedicated to perfecting
scientifically proven skincare that yields visible results," said
Jasson Gilmore, Senior Vice
President, U.S. Aesthetics. "The formulations of the new products
continue the legacy of promoting skin health and addressing key
patient concerns like acne."
In clinical studies, participants who used the
SkinMedica® Acne Clarifying Treatment and Pore Purifying
Gel Cleanser noticed clearer skin while reporting that the products
did not dry their skin out. Additionally, clinical study
participants noted the treatment regimen helped calm their
skin.3 The SkinMedica® approach to addressing
acne focuses on efficacy while respecting the skin barrier to help
break the acne cycle by balancing sebum, soothing visible redness,
and preserving the microbiome.
"Navigating the challenges posed by acne can be difficult, and
most acne products are effective at targeting acne but ignore the
impact of the ingredients on the skin barrier," said Dr.
Mona Gohara, board-certified
dermatologist and associate clinical professor at Yale University. "My patients often find themselves
in a bind when choosing acne products that treat acne but don't
compromise the skin barrier. I am excited to offer my patients
these new products from SkinMedica®, which focus on
sebum regulation and barrier protection to create a desirable
balance of low irritation with strong efficacy."
The SkinMedica® Acne Clarifying Treatment is
formulated with 2% encapsulated salicylic acid, which proactively
guards against future breakouts. The product also includes
ingredients like niacinamide and bakuchiol, which work together to
reduce the appearance of discoloration and post-acne marks while
refining pores and enhancing skin tone. With each application, this
treatment becomes a shield, preserving the skin's natural barrier.
MSRP $66.
Complementing the Acne Clarifying Treatment is the
SkinMedica® Pore Purifying Cleanser, which is infused
with salicylic acid, a beta-hydroxy acid, to help remove impurities
while a potent blend of antioxidants and soothing botanicals like
aloe and chamomile caress the skin, leaving behind a soft and
refreshed canvas. MSRP $46.
The new SkinMedica® products are available for
purchase at SkinMedica.com and through a network of licensed
physicians and medically supervised spas. To experience the
SkinMedica® Pore Purifying Pro-Infusion Serum for
DiamondGlow®, find a provider by visiting
DiamondGlow.com. For more information follow @SkinMedica on
Instagram.
About Allergan Aesthetics
At Allergan Aesthetics, an
AbbVie company, we develop, manufacture, and market a portfolio of
leading aesthetics brands and products. Our aesthetics portfolio
includes facial injectables, body contouring, plastics, skin care,
and more. Our goal is to consistently provide our customers with
innovation, education, exceptional service, and a commitment to
excellence, all with a personal touch. For more information, visit
www.allerganaesthetics.com
About AbbVie
AbbVie's mission is to discover and
deliver innovative medicines and solutions that solve serious
health issues today and address the medical challenges of tomorrow.
We strive to have a remarkable impact on people's lives across
several key therapeutic areas – immunology, oncology, neuroscience,
and eye care – and products and services in our Allergan Aesthetics
portfolio. For more information about AbbVie, please visit us at
www.abbvie.com. Follow @abbvie on LinkedIn, Facebook, Instagram, X
(formerly Twitter), and YouTube.
Forward-Looking Statements
Some statements in this news release are, or may be considered,
forward-looking statements for purposes of the Private Securities
Litigation Reform Act of 1995. The words "believe," "expect,"
"anticipate," "project" and similar expressions and uses of future
or conditional verbs, generally identify forward-looking
statements. AbbVie cautions that these forward-looking statements
are subject to risks and uncertainties that may cause actual
results to differ materially from those expressed or implied in the
forward-looking statements. Such risks and uncertainties include,
but are not limited to, challenges to intellectual property,
competition from other products, difficulties inherent in the
research and development process, adverse litigation or government
action, and changes to laws and regulations applicable to our
industry. Additional information about the economic, competitive,
governmental, technological and other factors that may affect
AbbVie's operations is set forth in Item 1A, "Risk Factors," of
AbbVie's 2023 Annual Report on Form 10-K, which has been filed with
the Securities and Exchange Commission, as updated by its
subsequent Quarterly Reports on Form 10-Q. AbbVie undertakes no
obligation, and specifically declines, to release publicly any
revisions to forward-looking statements as a result of subsequent
events or developments, except as required by law.
DiamondGlow® Uses
The
DiamondGlow® device is a general dermabrasion device
that gently removes the top layer of skin and delivers topical
cosmetic serums onto the skin.
DiamondGlow® Important Safety
Information
The DiamondGlow® treatment is not for
everyone. You should not have a DiamondGlow® treatment
if you have compromised skin quality. Tell your provider if you are
pregnant or lactating, or if you have any medical conditions,
including allergies, and if you are using topical medications on
the area to be treated.
Typical side effects include a scratchy, stinging sensation
during the treatment and temporary tightness, redness or slight
swelling after the treatment. Rare serious side effects may also
occur and include severe skin irritation and allergic
reactions.
SkinMedica® Pro-Infusion Serums
Disclaimer
SkinMedica® Pro-Infusion Serums
are intended to meet the FDA's definition of a cosmetic product, an
article applied to the human body to cleanse, beautify, promote
attractiveness, and alter appearances. These products are not
intended to be drugs that diagnose, treat, cure, or prevent any
disease or condition. These products have not been approved by the
FDA and the statements have not been evaluated by the FDA.
Please talk to your provider for additional information.
SkinMedica® Important Information
Most SkinMedica® products are intended to meet
the FDA's definition of a cosmetic product, an article applied to
the human body to cleanse, beautify, promote attractiveness, and
alter appearances. These SkinMedica® products are not
intended to be drug products that diagnose, treat, cure, or prevent
any disease or condition. These products have not been approved by
the FDA and the statements have not been evaluated by the
FDA.
SkinMedica® Acne Clarifying Treatment is an
over-the-counter drug product which is formulated and marketed
pursuant to FDA's governing regulations set forth at 21 CFR Part
333 Subpart D.
For more information, please talk to your provider or visit
SkinMedica.com and DiamondGlow.com. To report an adverse
reaction, please call Allergan at 1-800-433-8871.
BOTOX® COSMETIC IMPORTANT SAFETY INFORMATION AND
APPROVED USES
IMPORTANT SAFETY INFORMATION
BOTOX®
Cosmetic may cause serious side effects that can be life
threatening. Get medical help right away if you have any of these
problems any time (hours to weeks) after injection of
BOTOX® Cosmetic:
- Problems swallowing, speaking, or breathing, due to
weakening of associated muscles, can be severe and result in loss
of life. You are at the highest risk if these problems are
pre-existing before injection. Swallowing problems may last for
several months.
- Spread of toxin effects. The effect of botulinum toxin
may affect areas away from the injection site and cause serious
symptoms including: loss of strength and all-over muscle weakness,
double vision, blurred vision and drooping eyelids, hoarseness or
change or loss of voice, trouble saying words clearly, loss of
bladder control, trouble breathing, and trouble swallowing.
BOTOX® Cosmetic dosing units are not the same as,
or comparable to, any other botulinum toxin product.
There has not been a confirmed serious case of spread of toxin
effect when BOTOX® Cosmetic has been used at the
recommended dose to treat frown lines, crow's feet lines, and/or
forehead lines.
BOTOX® Cosmetic may cause loss of strength or general
muscle weakness, vision problems, or dizziness within hours to
weeks of taking BOTOX® Cosmetic. If this happens, do
not drive a car, operate machinery, or do other dangerous
activities.
Serious and/or immediate allergic reactions have been
reported. They include: itching, rash, red itchy welts,
wheezing, asthma symptoms, or dizziness or feeling faint. Get
medical help right away if you are wheezing or have asthma
symptoms, or if you become dizzy or faint.
Do not receive BOTOX® Cosmetic if
you: are allergic to any of the ingredients in
BOTOX® Cosmetic (see Medication Guide for ingredients);
had an allergic reaction to any other botulinum toxin product such
as Myobloc® (rimabotulinumtoxinB), Dysport®
(abobotulinumtoxinA), or Xeomin® (incobotulinumtoxinA);
have a skin infection at the planned injection site.
Tell your doctor about all your muscle or nerve
conditions, such as ALS or Lou
Gehrig's disease, myasthenia gravis, or Lambert-Eaton
syndrome, as you may be at increased risk of serious side effects
including difficulty swallowing and difficulty breathing from
typical doses of BOTOX® Cosmetic.
Tell your doctor about all your medical conditions,
including: plans to have surgery; had surgery on your face; have
trouble raising your eyebrows; drooping eyelids; any other abnormal
facial change; are pregnant or plan to become pregnant (it is not
known if BOTOX® Cosmetic can harm your unborn baby); are
breast-feeding or plan to (it is not known if BOTOX®
Cosmetic passes into breast milk).
Tell your doctor about all the medicines you take,
including prescription and over-the-counter medicines, vitamins,
and herbal supplements. Using BOTOX® Cosmetic with
certain other medicines may cause serious side effects. Do not
start any new medicines until you have told your doctor that you
have received BOTOX® Cosmetic in the past.
Tell your doctor if you have received any other botulinum toxin
product in the last 4 months; have received injections of botulinum
toxin such as Myobloc®, Dysport®, or
Xeomin® in the past (tell your doctor exactly which
product you received); have recently received an antibiotic by
injection; take muscle relaxants; take an allergy or cold medicine;
take a sleep medicine; take aspirin-like products or blood
thinners.
Other side effects of BOTOX® Cosmetic
include: dry mouth; discomfort or pain at the injection
site; tiredness; headache; neck pain; and eye problems: double
vision, blurred vision, decreased eyesight, drooping eyelids and
eyebrows, swelling of your eyelids and dry eyes.
Approved Uses
BOTOX® Cosmetic is a prescription medicine that is
injected into muscles and used to temporarily improve the look of
moderate to severe forehead lines, crow's feet lines, and frown
lines between the eyebrows in adults.
For more information refer to the Medication Guide or talk with
your doctor.
To report a side effect, please call Allergan at
1-800-678-1605.
Please see BOTOX® Cosmetic full Product
Information including Boxed Warning and Medication Guide.
References:
- AAD
(https://www.aad.org/public/diseases/acne/causes/acne-causes)
- Kline. Prograde Skincare Report. 2022.(According to Kline's
Physician-Dispensed Skin Care: US Perception and Satisfaction
Survey 2022, physicians noted that acne was the most common skin
condition that patients visit physician's office for, followed by
fine lines/wrinkles, sagging skin, and pigmentation.)
- Data on file at SkinMedica®
View original content to download
multimedia:https://www.prnewswire.com/news-releases/skinmedica-empowers-clear-skin-confidence-with-a-new-modern-approach-to-acne-302111109.html
SOURCE AbbVie